Page last updated: 2024-09-03

imatinib mesylate and Venous Thromboembolism

imatinib mesylate has been researched along with Venous Thromboembolism in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Breccia, M; Chistolini, A; Di Prima, A; Fiori, L; Scalzulli, E; Serrao, A1

Other Studies

1 other study(ies) available for imatinib mesylate and Venous Thromboembolism

ArticleYear
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.
    Clinical drug investigation, 2020, Volume: 40, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aniline Compounds; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Retrospective Studies; Venous Thromboembolism

2020
chemdatabank.com